Trailing-twelve-month (TTM) revenue is $4.74 Billion with a year-over-year growth of +5.12%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $1,168,153,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2026-01-03 | $1,215,267,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-04 |
| Q1 FY2026Period ended 2026-04-04 | $1,166,352,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-07-04 | $1,192,764,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $4,742,536,000 |
Current P/S: $1,138,105,664 market capitalization ÷ $4,742,536,000 TTM revenue = 0.24x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:55:27.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $1.19B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:57:06.233Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| Non-Perishable | $2.1B | $2.0B | $2.3B | $2.6B | $2.8B | $2.9B |
| Perishable | $1.1B | $1.1B | $1.3B | $1.4B |
$4.74B
$4.74 Billion
+5.12%
vs. $4.51B a year ago (TTM)
+8.88%
5 Year compound annual growth rate
1 Year
+5.12%
3 Year
+7.41%
5 Year
+8.88%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.69B | +$317.26M | +7.26% |
| 2024 | $4.37B | +$402.05M | +10.13% |
| 2023 | $3.97B | +$391.35M | +10.94% |
| 2022 | $3.58B | +$498.52M | +16.19% |
| 2021 | $3.08B | ($55.06M) | (1.76%) |
| 2020 |
TTM Growth
+5.12%
3-Year CAGR
+7.41%
5-Year CAGR
+8.88%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:57:06.233Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $1.6B |
| $1.8B |
| $3.13B |
| +$575.02M |
| +22.47% |
| 2019 | $2.56B | +$271.96M | +11.89% |
| 2018 | $2.29B | +$212.19M | +10.22% |
| 2017 | $2.08B | +$243.93M | +13.32% |
